Login Register Cart 0
Generic placeholder image

Current Bioactive Compounds

Editor-in-Chief

ISSN (Print): 1573-4072
ISSN (Online): 1875-6646

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Synthesis and Antimycobacterial Activity of 3-(Arylaminomethyl)-5- (Pyridin-4-yl)-1,3,4-Oxadiazole-(3H)-thi-2-One Derivatives Against Mycobacterium Tuberculosis H37rv Strain

Author(s): Mohammad Asif* and Mohd Imran

Volume 17, Issue 3, 2021

Published on: 07 May, 2020

Page: [261 - 266] Pages: 6

DOI: 10.2174/1573407216999200507122605

Price: $65

Abstract

Background: Oxadiazole derivatives are the biologically active heterocyclic compounds. Thus, we synthesized a series of Mannich bases, 3-(arylaminomethyl)-5-(pyridin- 4-yl)-1,3,4-oxadiazole-(3H)-thi-2-one derivatives(3a-3g) were synthesized from Isoniazid [INH (1)], a first line antimycobacterial drug, and these compounds were evaluated as antimycobacterial agents.

Methods: The INH was reacted with potassium hydroxide and carbon disulfide to give 5-(pyridin- 4-yl)-1,3,4-oxadiazole-2(3H)-thione (2), followed by reacting compound 2 with appropriate aromatic amines in the presence of formaldehyde to obtain desired compounds (3a-3g). The structures of these compounds have been established by IR, 1H-NMR, Mass spectral and elemental analysis. These synthesized compounds (3a-3g) were evaluated for their antimycobacterial activity against M. tuberculosis H37Rv strain.

Results: All the synthesized compounds (3a-3g) exhibited antimycobacterial activity and were compared to reference drugs Streptomycin (MIC value of 6.25μg/mL), INH (MIC value of 3.125μg/mL) and pyrazinamide (MIC value of 3.125μg/mL). Compounds 3c and 3e exhibited the most promising antimycobacterial activity.

Conclusion: All the title compounds were synthesized and exhibited promising antimycobacterial activity against M. tuberculosis H37Rv strain.

Keywords: Oxadiazole, pyridine, antitubercular, mannich bases, antimycobacterial activity, antituberculosis.

Graphical Abstract

[1]
Asif, M. A review of antimycobacterial drugs in development. Mini Rev. Med. Chem., 2012, 12(13), 1404-1418.
[PMID: 22625412]
[2]
Asif, M. Study of clinically used and recently developed antimycobacterial agents. Orient. Pharm. Exp. Med., 2012, 12, 15-34.
[http://dx.doi.org/10.1007/s13596-011-0020-8]
[3]
Asif, M.; Singh, A. Synthesis and anti-tubercular activity of 6-(4-Chloro/Methyl-phenyl)-4-Arylidene-4,5-dihydropyridazin-3(2H)-one derivatives against Mycobacterium tuberculosis. Lett. Drug Des. Discov., 2015, 12(6), 500-504.
[http://dx.doi.org/10.2174/157018081206150507130832]
[4]
Asif, M.; Singh, A.; Lakshmayya, H.A.; Siddiqui, A.A. Anticonvulsant and antitubercular activities of 6-Phenyl/Biphenyl-4-yl-2-[2-(pyridin-2-ylamino)-ethyl]-and6-(Biphenyl-4yl)-2-(2N-subtituted amin-1-yl)-ethyl derivatives of 4,5-dihyropyridazin-3(2H)-one. Lett. Drug Des. Discov., 2013, 10(7), 651-660.
[http://dx.doi.org/10.2174/1570180811310070013]
[5]
Husain, A.; Ahmad, A.; Bhandari, A.; Ram, V. Synthesis and antitubercular activity of pyridazinone derivatives. J. Chil. Chem. Soc., 2011, 56(3), 778-780.
[http://dx.doi.org/10.4067/S0717-97072011000300013]
[6]
Dye, C.; Scheele, S.; Dolin, P.; Pathania, V.; Raviglione, M.C. Consensus statement. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA, 1999, 282(7), 677-686.
[http://dx.doi.org/10.1001/jama.282.7.677] [PMID: 10517722]
[7]
Nahid, P.; Pai, M.; Hopewell, P.C. Advances in the diagnosis and treatment of tuberculosis. Proc. Am. Thorac. Soc., 2006, 3(1), 103-110.
[http://dx.doi.org/10.1513/pats.200511-119JH] [PMID: 16493157]
[8]
Scientific Facts on Drug-resistant Tuberculosis, Green Facts , 2008; pp. 12-18. Available at: https://www.greenfacts.org/en/tuberculosis/tuberculosis-greenfacts-level2.pdf
[9]
Barry, C.; Mizrahi, V.; Boshoff, H. Effects of pyrazinamide on fatty acid synthesis by whole Mycobacterial cells and purified fatty acid synthase I. J. Bacteriol., 2002, 8, 2167-2172.
[10]
Yasir, A.; Jerald, C. Advances in tuberculosis vaccine strategies. Nat. Rev. Microb., 2006, 4(6), 469-476.
[11]
Attimarad, M.; Rajasekran, S.; Rao, G. Synthesis and anti-tuberculosis activity of some 5-phenyl-4-substituted amino-3-mercapto(4H)1,2,4-triazoles. Indian J. Pharm. Sci., 2000, 65, 475-477.
[12]
Pandeya, S.N. A text book of pharmaceutical organic chemistry (heterocyclic and biomolecules), 2nd ed.; SG publisher: Varansi, 2003, pp. 108-113.
[13]
Gavin, H.D. De Novo synthesis of substituted pyridines. Tetrahedron, 2004, 60, 6043-6606.
[http://dx.doi.org/10.1016/j.tet.2004.04.043]
[14]
Attia, A.M.; Mansour, H.A.; Almehdi, A.A.; Abbasi, M.M. Synthesis of some pyridine ribosides and their biological activity. Nucleosides Nucleotides, 1999, 18(10), 2301-2306.
[http://dx.doi.org/10.1080/07328319908044882] [PMID: 10616731]
[15]
Chezal, J-M.; Paeshuyse, J.; Gaumet, V.; Canitrot, D.; Maisonial, A.; Lartigue, C.; Gueiffier, A.; Moreau, E.; Teulade, J.C.; Chavignon, O.; Neyts, J. Synthesis and antiviral activity of an imidazo[1,2-a]pyrrolo[2,3-c]pyridine series against the bovine viral diarrhea virus. Eur. J. Med. Chem., 2010, 45(5), 2044-2047.
[http://dx.doi.org/10.1016/j.ejmech.2010.01.023] [PMID: 20149501]
[16]
Nicolaou, K.C.; Scarpelli, R.; Bollbuck, B.; Werschkun, B.; Pereira, M.M.; Wartmann, M.; Altmann, K.H.; Zaharevitz, D.; Gussio, R.; Giannakakou, P. Chemical synthesis and biological properties of pyridine epothilones. Chem. Biol., 2000, 7(8), 593-599.
[http://dx.doi.org/10.1016/S1074-5521(00)00006-5] [PMID: 11048950]
[17]
Son, J-K.; Zhao, L.X.; Basnet, A.; Thapa, P.; Karki, R.; Na, Y.; Jahng, Y.; Jeong, T.C.; Jeong, B.S.; Lee, C.S.; Lee, E.S. Synthesis of 2,6-diaryl-substituted pyridines and their antitumor activities. Eur. J. Med. Chem., 2008, 43(4), 675-682.
[http://dx.doi.org/10.1016/j.ejmech.2007.05.002] [PMID: 17673337]
[18]
Romagnoli, R. Synthesis and biological evaluation of 2-amino-3-(30,40,50-trimethoxybenzoyl)-6-substituted-4,5,6,7-tetrahydrothieno[2,3-c]pyridine derivatives antimitotic agents and inhibitors of tubulin polymerization. Bioorg. Med. Chem. Lett., 2008, 5041-5045.
[http://dx.doi.org/10.1016/j.bmcl.2008.08.006] [PMID: 18725179]
[19]
Dias, L.R.S.; Santos, M.B.; Albuquerque, Sd.; Castro, H.C.; de Souza, A.M.; Freitas, A.C.; DiVaio, M.A.; Cabral, L.M.; Rodrigues, C.R. Synthesis, in vitro evaluation, and SAR studies of a potential antichagasic 1H-pyrazolo[3,4-b]pyridine series. Bioorg. Med. Chem., 2007, 15(1), 211-219.
[http://dx.doi.org/10.1016/j.bmc.2006.09.067] [PMID: 17064907]
[20]
Shi, F.; Li, C.; Xia, M.; Miao, K.; Zhao, Y.; Tu, S.; Zheng, W.; Zhang, G.; Ma, N. Green chemoselective synthesis of thiazolo[3,2-a]pyridine derivatives and evaluation of their antioxidant and cytotoxic activities. Bioorg. Med. Chem. Lett., 2009, 19(19), 5565-5568.
[http://dx.doi.org/10.1016/j.bmcl.2009.08.046] [PMID: 19729303]
[21]
Zhuravel’, I.O.; Kovalenko, S.M.; Ivachtchenko, A.V.; Balakin, K.V.; Kazmirchuk, V.V. Synthesis and antimicrobial activity of 5-hydroxymethyl- 8-methyl-2-(N-arylimino)-pyrano[2,3-c]pyridine-3-(N-aryl)-carboxamides. Bioorg. Med. Chem. Lett., 2005, 15(24), 5483-5487.
[http://dx.doi.org/10.1016/j.bmcl.2005.08.081] [PMID: 16183276]
[22]
Bhatia, M.S. Synthesis and QSAR analysis of 5-substituted (arylmethylene)pyridin-2-amine derivatives as potential antibacterials. Inter. J. Drug Discov., 2009, 1(1), 1-9.
[http://dx.doi.org/10.9735/0975-4423.1.1.1-9]
[23]
Ghattas, A.G.; El-Sherief, H.A.; Abdel Rahman, A.E.; Mahmoud, A.M. Synthesis of some new heterocyclic 1,3,4-oxadiazoles with antibacterial activity. Pharmazie, 1982, 37(6), 410-412.
[PMID: 7122680]
[24]
Nayak, N. JurupulaRamprasad, J.; Dalimba, U.; Yogeeswari, P.; Sriram D. Synthesis and antimycobacterial screening of new N-(4-(5-aryl-3-(5- methyl-1,3,4-oxadiazol-2-yl)-1H-pyrazol-1-yl)phenyl)-4-amide derivatives. Chin. Chem. Lett., 2016, 27, 365-369.
[http://dx.doi.org/10.1016/j.cclet.2016.01.015]
[25]
Omar, F.; Mahfouz, N.; Rahman, M. Design, synthesis and antiinflammatory activity of some 1,3,4-oxadiazole derivatives. Eur. J. Med. Chem., 1996, 31(10), 819-825.
[http://dx.doi.org/10.1016/0223-5234(96)83976-6] [PMID: 22026938]
[26]
Aboraria, A.; Mahfouz, N.; El-Gendy, M. Novel 5-(2-hydroxyphenyl)-3-substituted-2,3-dihydro-1,3,4-oxadiazole-2-thion derivatives: Promising anticancer agents. Bioorg. Med. Chem., 2006, 4, 1236-1246.
[http://dx.doi.org/10.1016/j.bmc.2005.09.053]
[27]
Shah, H.; Bhatt, J.; Desai, N.; Trivedi, P. Synthesis of 2,5-disubstituted1,3,4-oxadiazoles as potential antimicrobial, anticancer and anti-HIV agents. Indian J. Chem., 1998, 37, 180-182.
[28]
Srivastava, A.; Pathak, R.; Bahel, S. Synthesis and fungicidal activity of 5-substituted 1,3,4-oxadiazole-2-thiones and related compounds. J. Indian Chem. Soc., 1990, 67, 606-607.
[29]
Shahar, M.; Siddiqui, A.; Ali, M.A. Synthesis and anti-tuberculostatic activity of novel 1,3,4-oxadiazole derivatives. J. Chin. Chem. Soc. (Taipei), 2007, 54, 5-8.
[http://dx.doi.org/10.1002/jccs.200700002]
[30]
Vijayraghavan, S.; Somani, R.; Shirodkar, P.; Kadam, V. Microwave assisted synthesis and antimicrobial activity of some newer Mannich bases. Int. J. Pharm. Tech. Res., 2009, 3, 811-815.
[31]
Joshi, S.; Khosla, N.; Tiwari, P. In vitro study of some medicinally important Mannich bases derived from antitubercular agent. Bioorg. Med. Chem., 2004, 12(3), 571-576.
[http://dx.doi.org/10.1016/j.bmc.2003.11.001] [PMID: 14738966]
[32]
Sriram, D.; Yogeeswari, P.; Reddy, S.P. Synthesis of pyrazinamide Mannich bases and its antitubercular properties. Bioorg. Med. Chem. Lett., 2006, 16(8), 2113-2116.
[http://dx.doi.org/10.1016/j.bmcl.2006.01.064] [PMID: 16464574]
[33]
Somani, R.; Shirodkar, P. Synthesis, antibacterial and antitubercular evaluation of some 1,3,4-oxadiazole analogues. Asian J. Chem., 2008, 20, 6189-6194.
[34]
Shirodkar, P.; Somani, R.; Toraskar, M.; Kadam, V. Synthesis and biological evaluation of 2,5-disubstituted 1,3,4-oxadiazole analogues. Ind. J. Pharm. Educ. Res., 2008, 42, 53-54.
[35]
Somani, R.; Shirodkar, P.; Kadam, V. Synthesis and antibacterial activity of some new 2,5-disubstituted-1,3,4-oxadiazole derivatives. Chin. J. Chem., 2008, 26, 1727-1731.
[http://dx.doi.org/10.1002/cjoc.200890312]
[36]
William, M.; Paul, C.; Elmer, W.; Stephen, D. Text book of Diagnostic Microbiology. Lippincot, 2002, 5, 935-937.
[37]
Somani, R.R.; Balkund, V.D.; Nikam, S.R.; Shirodkar, P.Y.; Zope, D.B. Synthesis, antibacterial and anti-tubercular evaluation of some 1,3,4-oxadiazole based mannich bases. Inter. J. Chem Tech. Res., 2013, 5(5), 2588-2592.
[38]
Lourenco, M.C.S.; deSouza, M.V.N.; Pinheiro, A.C.; Ferreira, M.L.; Goncalves, R.B.; Nogneira, T.C.M.; Peralta, M.A. Evaluation of antitubercular activity of nicotinic and isoniazid analogues. Arkivoc, 2007, 15, 181-191.
[39]
Gadegoni, H.; Manda, S.; Rangu, S. Synthesis and biological evaluation of some novel pyridazine based 1,3,4-oxadiazoles as potential antimicrobial agents. World J. Pharm. Pharm. Sci., 2015, 4(10), 1901-1909.

Rights & Permissions Print Cite
Article Metrics
19
World Immunization Week
© 2024 Bentham Science Publishers | Privacy Policy